A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2004
11/04/2004	US20040219562 Novel form of the PHGPx protein as a diagnostic marker for male infertility
11/04/2004	US20040219218 tablets or capsules of T3 or T4 or their salts in a uniform soft gel matrix that can be taken orally without chewing
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219174 Contraception process and administration form for the same
11/04/2004	US20040219156 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
11/03/2004	EP1472515A2 MINRs AS MODIFIERS FO INSULIN RECEPTOR SIGNALING AND METHODS OF USE
11/03/2004	EP1472376A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472272A1 Crystalline complexes of fluticasone 2-furoate
11/03/2004	EP1472271A1 Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy)-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid
11/03/2004	EP1472251A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471919A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
11/03/2004	EP1471905A1 Use of cholinesterase antagonists to treat insulin resistance
11/03/2004	EP1471891A2 Polymer-based compositions for sustained release
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1286957B1 Diphenylmethane derivatives
11/03/2004	EP1207884B1 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
11/03/2004	EP1206257B1 Use of amino acids for making medicines for treating insulin-resistance
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004	EP0722324B1 Pharmaceutical composition for immunoenhancement therapy
11/03/2004	CN1543570A Identifying compounds that modulate interaction of neuronal nitric oxide synthase and its inhibitor, useful e.g. for treating prediabetic states
11/03/2004	CN1543466A New use of specific cyclolignans
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543357A 5-CNAC as oral delivery agent for parathyroid hormone fragments
11/03/2004	CN1543349A Enhanced drug delivery in transdermal systems
11/03/2004	CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/03/2004	CN1173973C Benzocarbazole and indenoindole derived estrogenic agents
11/03/2004	CN1173964C Novel benzofuranone derivative and process for producing same
11/03/2004	CN1173929C Process for preparing adrenin beta-excitomotors by combinaion and disconnection method
11/03/2004	CN1173727C Chinese medicine liquor for clearing and activating main and collateral channels, and its preparation method
11/03/2004	CN1173725C Traditional Chinese prepared medicine for treating hyperthyreosis and simple thyrocele and its preparing process
11/03/2004	CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder
11/02/2004	US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004	US6812244 Naphthyl compounds, intermediates, compositions, and methods of use
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	US6812225 Pyschological disorders; antidepressants
11/02/2004	CA2296970C Neuropeptide y antagonists
10/2004
10/28/2004	WO2004091641A1 Follicle-stimulating hormone releasing agent
10/28/2004	WO2004091636A1 Phosphate derivatives of pharmaceutical products
10/28/2004	WO2004091635A1 Remedy for endometriosis and gynecologic diseases
10/28/2004	WO2004091630A1 Remedies for diseases to be applied to eye
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004072643A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r)
10/28/2004	WO2004054558A3 Reduction of breast density with 4-hydroxy tamoxifen
10/28/2004	WO2003077840A3 Method of modulating inflammatory response
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/28/2004	US20040215018 use as selective estrogen receptor modulators, and use in inhibiting bone loss, cardiovascular disease, and breast and uterine carcinoma
10/28/2004	US20040215014 Auroyl cyclic amines for controlling behavior or appetite
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040213797 Conjugates for the modulation of immune responses
10/28/2004	US20040213442 Novel fatty acids analogous
10/28/2004	CA2527175A1 Remedies for diseases to be applied to eye
10/28/2004	CA2521842A1 Phosphate derivatives of pharmaceutical products
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470150A2 Corticosteroids nitrate derivatives
10/27/2004	EP1470137A1 Edg receptor agonists
10/27/2004	EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
10/27/2004	EP1469878A2 Fgfr agonists
10/27/2004	EP1469862A2 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
10/27/2004	EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists
10/27/2004	EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
10/27/2004	CN1541220A 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents
10/27/2004	CN1541217A Chemical compounds
10/27/2004	CN1541126A Microprojection array having beneficial agent contg coating
10/27/2004	CN1541107A Growth factor complex
10/27/2004	CN1541102A Somatostain agonists
10/27/2004	CN1541090A Prepn. of sustained release pharmaceutical compsn.
10/27/2004	CN1172917C Steroid receptor modulator compounds and methods
10/27/2004	CN1172667C Application of tea polyphenol in treating thyroid disease
10/27/2004	CN1172664C Agent for lowering prolactin
10/26/2004	US6809178 Polypeptide for use in the treatment of addison's disease
10/26/2004	US6809115 Mixture has a synergistic, weight loss effect
10/26/2004	US6809098 Compounds
10/26/2004	US6809095 Novel antitobesity and hypocholesterolemic compounds lower total cholesterol; increase high density lipoprotein (hdl) and decrease low denstiy lipoprotein
10/26/2004	US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
10/26/2004	US6808739 Drying method for selectively removing volatile components from wet coatings
10/21/2004	WO2004089917A2 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome
10/21/2004	WO2004089417A1 Drug-enclosing multilayer structure particulate and process for producing the same
10/21/2004	WO2004089362A1 2-cyanopyrroles and their analogues as ddp-iv inhibitors
10/21/2004	WO2004075822A3 Pharmaceutical composition for transdermal or transmucosal administration
10/21/2004	WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
10/21/2004	WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto
10/21/2004	US20040210080 3-(oxo, oxime, hydrazone, or alkylidene)-fluorene derivatives; can be synergistically combined with other anticarcinogenic, anticholesterol, anxiolytic agents, antidepressants or enzyme inhibitors; bone disorders
10/21/2004	US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles
10/21/2004	US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/21/2004	US20040209935 Pyrazole-derived kinase inhibitors and uses thereof
10/21/2004	US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments

1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 290